Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 639

1.

Significant association between urethral length measured by magnetic resonance imaging and urinary continence recovery after robot-assisted radical prostatectomy.

Kitamura K, China T, Kanayama M, Nagata M, Isotani S, Wakumoto Y, Muto S, Ide H, Horie S.

Prostate Int. 2019 Jun;7(2):54-59. doi: 10.1016/j.prnil.2018.06.003. Epub 2018 Jun 27.

2.

Endurological treatment trend of upper urinary urolithiasis in Japan from the Japanese Diagnosis Procedure Combination Database.

Isotani S, Noma Y, Wakumoto Y, Muto S, Horie S.

Int J Urol. 2019 Jun 30. doi: 10.1111/iju.14048. [Epub ahead of print] No abstract available.

PMID:
31257649
3.

An In Vitro System for Evaluating Molecular Targeted Drugs Using Lung Patient-Derived Tumor Organoids.

Takahashi N, Hoshi H, Higa A, Hiyama G, Tamura H, Ogawa M, Takagi K, Goda K, Okabe N, Muto S, Suzuki H, Shimomura K, Watanabe S, Takagi M.

Cells. 2019 May 20;8(5). pii: E481. doi: 10.3390/cells8050481.

4.

Automated Feedback Messages With Shichifukujin Characters Using IoT System-Improved Glycemic Control in People With Diabetes: A Prospective, Multicenter Randomized Controlled Trial.

Kobayashi T, Tsushita K, Nomura E, Muramoto A, Kato A, Eguchi Y, Onoue T, Goto M, Muto S, Yatsuya H, Arima H.

J Diabetes Sci Technol. 2019 Jul;13(4):796-798. doi: 10.1177/1932296819851785. Epub 2019 May 20. No abstract available.

PMID:
31104490
5.

Prognostic impact of serum transthyretin in patients with non-small cell lung cancer.

Shimura T, Shibata M, Inoue T, Owada-Ozaki Y, Yamaura T, Muto S, Hasegawa T, Shio Y, Suzuki H.

Mol Clin Oncol. 2019 Jun;10(6):597-604. doi: 10.3892/mco.2019.1837. Epub 2019 Apr 3.

6.

Evaluation of gastric acid suppression with vonoprazan using calcium carbonate breath test.

Miyamoto S, Tsuda M, Kato M, Mabe K, Muto S, Ono S, Shimizu Y, Sakamoto N.

J Clin Biochem Nutr. 2019 Mar;64(2):174-179. doi: 10.3164/jcbn.18-75. Epub 2018 Nov 28.

7.

Peritoneal Dialysis and Malignancy: An Experience With a Patient Complicated by Gastric Carcinoma.

Akimoto T, Muto S, Kutsuwada T, Kutsuwada K, Nagata D.

Clin Med Insights Case Rep. 2019 Mar 12;12:1179547619835176. doi: 10.1177/1179547619835176. eCollection 2019.

8.

Standard protocol for the total red blood cell Pig-a assay used in the interlaboratory trial organized by the Mammalian Mutagenicity Study Group of the Japanese Environmental Mutagen Society.

Chikura S, Kimoto T, Itoh S, Sanada H, Muto S, Horibata K.

Genes Environ. 2019 Feb 27;41:5. doi: 10.1186/s41021-019-0121-z. eCollection 2019.

9.

Corrigendum to: Twinned/untwinned catalytic gold nanoparticles identified by applying a convolutional neural network to their Hough transformed Z-contrast images.

Yamamoto Y, Hattori M, Ohyama J, Satsuma A, Tanaka N, Muto S.

Microscopy (Oxf). 2019 Apr 1;68(2):194. doi: 10.1093/jmicro/dfz008. No abstract available.

PMID:
30789203
10.

Long-term observation of antimicrobial susceptibility and molecular characterisation of Campylobacter jejuni isolated in a Japanese general hospital 2000-2017.

Yamada K, Saito R, Muto S, Sasaki M, Murakami H, Aoki K, Ishii Y, Tateda K.

J Glob Antimicrob Resist. 2019 Sep;18:59-63. doi: 10.1016/j.jgar.2019.02.001. Epub 2019 Feb 10.

PMID:
30753906
11.

Proposal for Measuring Magnetism with Patterned Apertures in a Transmission Electron Microscope.

Negi D, Spiegelberg J, Muto S, Thersleff T, Ohtsuka M, Schönström L, Tatsumi K, Rusz J.

Phys Rev Lett. 2019 Jan 25;122(3):037201. doi: 10.1103/PhysRevLett.122.037201.

PMID:
30735420
12.

Different Effects on Fluid Distribution between Tolvaptan and Furosemide in a Liver Cirrhosis Patient with Chronic Kidney Disease.

Nagayama I, Masuda T, Nakagawa S, Murakami T, Ohara K, Matsuoka R, Kobayashi T, Maeshima A, Akimoto T, Saito O, Muto S, Nagata D.

Intern Med. 2019 Jun 1;58(11):1587-1591. doi: 10.2169/internalmedicine.2174-18. Epub 2019 Feb 1.

13.

Effects of the sodium-glucose cotransporter 2 inhibitor dapagliflozin on fluid distribution: A comparison study with furosemide and tolvaptan.

Ohara K, Masuda T, Murakami T, Imai T, Yoshizawa H, Nakagawa S, Okada M, Miki A, Myoga A, Sugase T, Sekiguchi C, Miyazawa Y, Maeshima A, Akimoto T, Saito O, Muto S, Nagata D.

Nephrology (Carlton). 2019 Sep;24(9):904-911. doi: 10.1111/nep.13552. Epub 2019 May 2.

PMID:
30578654
14.

Environmental high-voltage S/TEM combined with a quadrupole mass spectrometer for concurrent in situ structural characterization and detection of product gas molecules associated with chemical reactions.

Muto S, Arai S, Higuchi T, Orita K, Ohta S, Tanaka H, Suganuma T, Ibe M, Hirata H.

Microscopy (Oxf). 2019 Apr 1;68(2):185-188. doi: 10.1093/jmicro/dfy141.

PMID:
30576560
15.

Multiple Sclerosis Drug Fingolimod Induces Thrombotic Microangiopathy in Deoxycorticosterone Acetate/Salt Hypertension.

Iwazu Y, Muto S, Ioka T, Watanabe Y, Iwazu K, Kusano E, Nagata D.

Hypertension. 2018 Sep;72(3):776-784. doi: 10.1161/HYPERTENSIONAHA.117.10655.

PMID:
30354753
16.

Respect and admiration differentially activate the anterior temporal lobe.

Nakatani H, Muto S, Nonaka Y, Nakai T, Fujimura T, Okanoya K.

Neurosci Res. 2019 Jul;144:40-47. doi: 10.1016/j.neures.2018.09.003. Epub 2018 Sep 9.

PMID:
30208305
17.

Twinned/untwinned catalytic gold nanoparticles identified by applying a convolutional neural network to their Hough transformed Z-contrast images.

Yamamoto Y, Hattori M, Ohyama J, Satsuma A, Tanaka N, Muto S.

Microscopy (Oxf). 2018 Dec 1;67(6):321-330. doi: 10.1093/jmicro/dfy036. Erratum in: Microscopy (Oxf). 2019 Apr 1;68(2):194.

PMID:
30124934
18.

Hemolytic Uremic Syndrome: An Increasingly Recognized Public Health Problem.

Murakami T, Akimoto T, Yamazaki T, Yoshizawa H, Okada M, Miki A, Nakagawa S, Ohara K, Sugase T, Masuda T, Kobayashi T, Saito O, Muto S, Nagata D.

Clin Med Insights Case Rep. 2018 Jul 3;11:1179547618785137. doi: 10.1177/1179547618785137. eCollection 2018.

19.

Outbreak of Enterohemorrhagic Escherichia coli O157:H7 Infection Associated with Minced Meat Cutlets Consumption in Kanagawa, Japan.

Furukawa I, Suzuki M, Masaoka T, Nakajima N, Mitani E, Tasaka M, Teranishi H, Matsumoto Y, Koizumi M, Ogawa A, Oota Y, Homma S, Sasaki K, Satoh H, Sato K, Muto S, Anan Y, Kuroki T.

Jpn J Infect Dis. 2018 Nov 22;71(6):436-441. doi: 10.7883/yoken.JJID.2017.495. Epub 2018 Jul 31.

20.

Simple risk model and score for predicting of incident atrial fibrillation in Japanese.

Hamada R, Muto S.

J Cardiol. 2019 Jan;73(1):65-72. doi: 10.1016/j.jjcc.2018.06.005. Epub 2018 Jul 29.

PMID:
30064946
21.

Valacyclovir Neurotoxicity and Nephrotoxicity in an Elderly Patient Complicated by Hyponatremia.

Murakami T, Akimoto T, Okada M, Hishida E, Sugase T, Miki A, Kohara M, Yoshizawa H, Masuda T, Kobayashi T, Saito O, Muto S, Nagata D.

Drug Target Insights. 2018 Jun 25;12:1177392818782899. doi: 10.1177/1177392818782899. eCollection 2018.

22.

Surveillance after prostate focal therapy.

Tay KJ, Amin MB, Ghai S, Jimenez RE, Kench JG, Klotz L, Montironi R, Muto S, Rastinehad AR, Turkbey B, Villers A, Polascik TJ.

World J Urol. 2019 Mar;37(3):397-407. doi: 10.1007/s00345-018-2363-y. Epub 2018 Jun 9. Review.

PMID:
29948045
23.

Unmasking a sustained negative effect of SGLT2 inhibition on body fluid volume in the rat.

Masuda T, Watanabe Y, Fukuda K, Watanabe M, Onishi A, Ohara K, Imai T, Koepsell H, Muto S, Vallon V, Nagata D.

Am J Physiol Renal Physiol. 2018 Sep 1;315(3):F653-F664. doi: 10.1152/ajprenal.00143.2018. Epub 2018 May 23.

24.

Prognostic Impact of Tumor Mutation Burden in Patients With Completely Resected Non-Small Cell Lung Cancer: Brief Report.

Owada-Ozaki Y, Muto S, Takagi H, Inoue T, Watanabe Y, Fukuhara M, Yamaura T, Okabe N, Matsumura Y, Hasegawa T, Ohsugi J, Hoshino M, Shio Y, Nanamiya H, Imai JI, Isogai T, Watanabe S, Suzuki H.

J Thorac Oncol. 2018 Aug;13(8):1217-1221. doi: 10.1016/j.jtho.2018.04.003. Epub 2018 Apr 12.

25.

Quantitative T-cell repertoire analysis of peripheral blood mononuclear cells from lung cancer patients following long-term cancer peptide vaccination.

Takeda K, Kitaura K, Suzuki R, Owada Y, Muto S, Okabe N, Hasegawa T, Osugi J, Hoshino M, Tsunoda T, Okumura K, Suzuki H.

Cancer Immunol Immunother. 2018 Jun;67(6):949-964. doi: 10.1007/s00262-018-2152-x. Epub 2018 Mar 22.

PMID:
29568993
26.

Correlation between the results of in vitro and in vivo chromosomal damage tests in consideration of exposure levels of test chemicals.

Yamamura E, Aruga C, Muto S, Baba N, Uno Y.

Genes Environ. 2018 Mar 6;40:6. doi: 10.1186/s41021-018-0094-3. eCollection 2018.

27.

Intrauterine balloon tamponade and bilateral hydronephrosis: do they really have a cause-effect relationship?

Matsubara S, Morita T, Muto S, Suzuki T.

J Obstet Gynaecol. 2018 May;38(4):587. doi: 10.1080/01443615.2017.1379969. Epub 2018 Mar 7. No abstract available.

PMID:
29514526
28.

[Recent Advances in Immunotherapy for Non-Small Cell Lung Cancer].

Muto S, Suzuki H.

Gan To Kagaku Ryoho. 2018 Feb;45(2):212-216. Japanese.

PMID:
29483407
29.

Comparison of surgical outcomes after pneumonectomy and pulmonary function-preserving surgery for non-small cell lung cancer.

Higuchi M, Takagi H, Ozaki Y, Inoue T, Watanabe Y, Yamaura T, Fukuhara M, Muto S, Okabe N, Matsumura Y, Hasegawa T, Osugi J, Hoshino M, Shio Y, Suzuki H.

Fukushima J Med Sci. 2018 Apr 17;64(1):30-37. doi: 10.5387/fms.2017-10. Epub 2018 Feb 20.

30.

Family with sequence similarity 83, member B is a predictor of poor prognosis and a potential therapeutic target for lung adenocarcinoma expressing wild-type epidermal growth factor receptor.

Yamaura T, Ezaki J, Okabe N, Takagi H, Ozaki Y, Inoue T, Watanabe Y, Fukuhara M, Muto S, Matsumura Y, Hasegawa T, Hoshino M, Osugi J, Shio Y, Waguri S, Tamura H, Imai JI, Ito E, Yanagisawa Y, Honma R, Watanabe S, Suzuki H.

Oncol Lett. 2018 Feb;15(2):1549-1558. doi: 10.3892/ol.2017.7517. Epub 2017 Dec 5.

31.

Modulation of AKR1C2 by curcumin decreases testosterone production in prostate cancer.

Ide H, Lu Y, Noguchi T, Muto S, Okada H, Kawato S, Horie S.

Cancer Sci. 2018 Apr;109(4):1230-1238. doi: 10.1111/cas.13517. Epub 2018 Feb 19.

32.

Multicenter observational study on functional bowel disorders diagnosed using Rome III diagnostic criteria in Japan.

Ono M, Kato M, Miyamoto S, Tsuda M, Mizushima T, Ono S, Nakagawa M, Mabe K, Nakagawa S, Muto S, Shimizu Y, Kudo M, Katsuki S, Meguro T, Sakamoto N.

J Gastroenterol. 2018 Aug;53(8):916-923. doi: 10.1007/s00535-017-1428-9. Epub 2018 Jan 5.

PMID:
29305648
33.

Peritoneal Dialysis and Retroperitoneal Laparoscopic Radical Nephrectomy: A Favorable Experience With a Patient Complicated by Renal Cell Carcinoma.

Imai R, Akimoto T, Kimura T, Kohara M, Shimizu T, Oka K, Shuto M, Asakura M, Nagayama I, Takeda SI, Yagisawa T, Muto S, Nagata D.

Clin Med Insights Case Rep. 2017 Dec 10;10:1179547617746362. doi: 10.1177/1179547617746362. eCollection 2017.

34.

Surgically Diagnosed Primary Hepatic Angiosarcoma.

Tsunematsu S, Muto S, Oi H, Naka T, Kitagataya T, Sasaki R, Taya Y, Baba U, Tsukamoto Y, Uemura K, Kimura T, Ohara Y.

Intern Med. 2018 Mar 1;57(5):687-691. doi: 10.2169/internalmedicine.9318-17. Epub 2017 Nov 20.

35.

Influence of abdominal obesity and habitual behaviors on incident atrial fibrillation in Japanese.

Hamada R, Lee JS, Mori K, Watanabe E, Muto S.

J Cardiol. 2018 Feb;71(2):118-124. doi: 10.1016/j.jjcc.2017.07.008. Epub 2017 Nov 7.

36.

Long-term safety profile of tolvaptan in autosomal dominant polycystic kidney disease patients: TEMPO Extension Japan Trial.

Muto S, Okada T, Yasuda M, Tsubouchi H, Nakajima K, Horie S.

Drug Healthc Patient Saf. 2017 Oct 25;9:93-104. doi: 10.2147/DHPS.S142825. eCollection 2017. Erratum in: Drug Healthc Patient Saf. 2018 Jul 16;10:67-68.

37.

Novel semi-automated kidney volume measurements in autosomal dominant polycystic kidney disease.

Muto S, Kawano H, Isotani S, Ide H, Horie S.

Clin Exp Nephrol. 2018 Jun;22(3):583-590. doi: 10.1007/s10157-017-1486-6. Epub 2017 Nov 3.

PMID:
29101551
38.

Pleuroperitoneal Communication and Ovarian Cancer Complicating Peritoneal Dialysis: A Case Report of a Patient with End-Stage Kidney Disease.

Akimoto T, Yamazaki T, Kohara M, Nakagawa S, Kanai Y, Izawa S, Yamamoto H, Nakazawa E, Masuda T, Kobayashi T, Saito O, Muto S, Kusano E, Nagata D.

Clin Med Insights Case Rep. 2017 Oct 16;10:1179547617735818. doi: 10.1177/1179547617735818. eCollection 2017.

39.

Epidermal growth factor receptor mutation status is strongly associated with smoking status in patients undergoing surgical resection for lung adenocarcinoma.

Matsumura Y, Owada Y, Inoue T, Watanabe Y, Yamaura T, Fukuhara M, Muto S, Okabe N, Hasegawa T, Hoshino M, Osugi J, Higuchi M, Suzuki H.

Interact Cardiovasc Thorac Surg. 2017 Nov 1;25(5):690-695. doi: 10.1093/icvts/ivx207.

PMID:
29049789
40.

The efficacy of the Kampo medicine rikkunshito for chemotherapy-induced anorexia (RICH trial): study protocol for a randomized controlled trial.

Inoue T, Takagi H, Owada Y, Watanabe Y, Yamaura T, Fukuhara M, Muto S, Okabe N, Matsumura Y, Hasegawa T, Osugi J, Hoshino M, Higuchi M, Shio Y, Yokouchi H, Kanazawa K, Ohbuchi K, Fukushima T, Munakata M, Suzuki H.

Trials. 2017 Oct 18;18(1):485. doi: 10.1186/s13063-017-2227-6.

41.

Nephrotic Syndrome and a Retroperitoneal Mass: A Case Report of a Patient with Recurrent Invasive Thymoma.

Myoga H, Akimoto T, Mato N, Nakaya T, Murakami T, Yoshizawa H, Nakagawa S, Miki A, Masuda T, Kobayashi T, Ono Y, Saito O, Ueda Y, Muto S, Nagata D.

Intern Med. 2017 Dec 15;56(24):3317-3322. doi: 10.2169/internalmedicine.9224-17. Epub 2017 Oct 11.

42.

[Exploring the Possibility of New Biomarkers of Immune Checkpoint Inhibitors for Non-Small Cell Lung Cancer (NSCLC)].

Owada Y, Inoue T, Watanabe Y, Fukuhara M, Yamaura T, Muto S, Matsumura Y, Hasegawa T, Tanaka D, Kanno R, Ito E, Nanamiya H, Imai J, Isogai T, Watanabe S, Suzuki H.

Gan To Kagaku Ryoho. 2017 Sep;44(9):763-766. Japanese.

PMID:
28912405
43.

Efficacy and safety of saxagliptin in combination with insulin in Japanese patients with type 2 diabetes mellitus: a 16-week double-blind randomized controlled trial with a 36-week open-label extension.

Kadowaki T, Muto S, Ouchi Y, Shimazaki R, Seino Y.

Expert Opin Pharmacother. 2017 Dec;18(18):1903-1919. doi: 10.1080/14656566.2017.1379990. Epub 2017 Oct 12.

PMID:
28901796
44.

[I. History of Immunotherapy and Cancer Vaccine for Lung Cancer].

Suzuki H, Takagi H, Owada Y, Watanabe Y, Inoue T, Fukuhara M, Yamaura T, Muto S, Okabe N, Hasegawa T, Shio Y.

Gan To Kagaku Ryoho. 2017 Aug;44(8):646-649. Japanese. No abstract available.

PMID:
28860434
45.

Guidelines for treatment of renal injury during cancer chemotherapy 2016.

Horie S, Oya M, Nangaku M, Yasuda Y, Komatsu Y, Yanagita M, Kitagawa Y, Kuwano H, Nishiyama H, Ishioka C, Takaishi H, Shimodaira H, Mogi A, Ando Y, Matsumoto K, Kadowaki D, Muto S.

Clin Exp Nephrol. 2018 Feb;22(1):210-244. doi: 10.1007/s10157-017-1448-z. Review. No abstract available.

46.

Retroperitoneal Bleeding: An Experience During Prophylactic Anticoagulation in a Patient With Nephrotic Syndrome.

Okada M, Akimoto T, Kawamata M, Imai T, Hishida E, Kohara M, Miki A, Murakami T, Sugase T, Masuda T, Ono Y, Ueda Y, Saito O, Muto S, Nagata D.

Clin Med Insights Case Rep. 2017 Aug 1;10:1179547617723317. doi: 10.1177/1179547617723317. eCollection 2017.

47.

[Management of Chest Drain after Lung Resection].

Muto S, Suzuki H.

Kyobu Geka. 2017 Jul;70(8):683-687. Review. Japanese.

PMID:
28790289
48.

Molecular Characterization of Fluoroquinolone-Resistant Moraxella catarrhalis Variants Generated In Vitro by Stepwise Selection.

Yamada K, Saito R, Muto S, Kashiwa M, Tamamori Y, Fujisaki S.

Antimicrob Agents Chemother. 2017 Sep 22;61(10). pii: e01336-17. doi: 10.1128/AAC.01336-17. Print 2017 Oct.

49.

Clinical and pathological aspects of microscopic thymoma with myasthenia gravis and review of published reports.

Fukuhara M, Higuchi M, Owada Y, Inoue T, Watanabe Y, Yamaura T, Muto S, Hasegawa T, Suzuki H.

J Thorac Dis. 2017 Jun;9(6):1592-1597. doi: 10.21037/jtd.2017.05.22.

50.

Unmixing hyperspectral data by using signal subspace sampling.

Spiegelberg J, Muto S, Ohtsuka M, Pelckmans K, Rusz J.

Ultramicroscopy. 2017 Nov;182:205-211. doi: 10.1016/j.ultramic.2017.07.009. Epub 2017 Jul 10.

PMID:
28711769

Supplemental Content

Support Center